Breaking News, Financial News

Financial Report: AMRI 1Q08

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI

1Q Revenues: $53.6 million (+11%)

1Q Earnings: $4.7 million (+47%)

Comments: Total contract revenue increased to $45.3 million in the quarter (+10%).  Discovery Services revenue was $13.3 million (+34%). Development and Small Scale Manufacturing revenue was $13.2 million (+29%). Large Scale Manufacturing revenue dropped to $18.7 million (-11%). Allegra royalties were $8.2 million (+15%).

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters